NEW CANAAN, CT–(Marketwire – February 9, 2010) – Marshall Edwards, Inc. ( NASDAQ : MSHL ), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, announced that its Board of Directors has approved a reverse stock split of the company’s common stock
**Highly Recommended Books**Marshall Edwards, Inc.’s Action Intended to Regain Compliance With Nasdaq Share Price Rule, Benefit Shareholders (Marketwire)
February 9th, 2010
No Comments
